IL103311A0 - Formation of triple helix complexes of single stranded nucleic acids using nucleoside oligomers - Google Patents
Formation of triple helix complexes of single stranded nucleic acids using nucleoside oligomersInfo
- Publication number
- IL103311A0 IL103311A0 IL103311A IL10331192A IL103311A0 IL 103311 A0 IL103311 A0 IL 103311A0 IL 103311 A IL103311 A IL 103311A IL 10331192 A IL10331192 A IL 10331192A IL 103311 A0 IL103311 A0 IL 103311A0
- Authority
- IL
- Israel
- Prior art keywords
- formation
- nucleic acids
- single stranded
- stranded nucleic
- triple helix
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6839—Triple helix formation or other higher order conformations in hybridisation assays
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/15—Nucleic acids forming more than 2 strands, e.g. TFOs
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/15—Nucleic acids forming more than 2 strands, e.g. TFOs
- C12N2310/152—Nucleic acids forming more than 2 strands, e.g. TFOs on a single-stranded target, e.g. fold-back TFOs
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/31—Chemical structure of the backbone
- C12N2310/312—Phosphonates
- C12N2310/3125—Methylphosphonates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/32—Chemical structure of the sugar
- C12N2310/321—2'-O-R Modification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/33—Chemical structure of the base
- C12N2310/334—Modified C
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/35—Nature of the modification
- C12N2310/351—Conjugate
- C12N2310/3511—Conjugate intercalating or cleaving agent
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/35—Nature of the modification
- C12N2310/352—Nature of the modification linked to the nucleic acid via a carbon atom
- C12N2310/3521—Methyl
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US77208191A | 1991-10-07 | 1991-10-07 |
Publications (1)
Publication Number | Publication Date |
---|---|
IL103311A0 true IL103311A0 (en) | 1993-03-15 |
Family
ID=25093855
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL103311A IL103311A0 (en) | 1991-10-07 | 1992-10-01 | Formation of triple helix complexes of single stranded nucleic acids using nucleoside oligomers |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP0650526A4 (en) |
JP (1) | JPH07501936A (en) |
AU (2) | AU2785292A (en) |
CA (1) | CA2119890A1 (en) |
IL (1) | IL103311A0 (en) |
NZ (1) | NZ244606A (en) |
WO (1) | WO1993007295A1 (en) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1996018732A2 (en) * | 1994-12-15 | 1996-06-20 | Board Of Trustees Of The University Of Illinois | Sequence-specific inhibition of dna synthesis by triplex-forming oligonucleotides |
US6331617B1 (en) | 1996-03-21 | 2001-12-18 | University Of Iowa Research Foundation | Positively charged oligonucleotides as regulators of gene expression |
US5734040A (en) * | 1996-03-21 | 1998-03-31 | University Of Iowa Research Foundation | Positively charged oligonucleotides as regulators of gene expression |
US6274313B1 (en) | 1996-03-21 | 2001-08-14 | Pioneer-Hybrid International, Inc. | Oligonucleotides with cationic phosphoramidate internucleoside linkages and methods of use |
US5853993A (en) * | 1996-10-21 | 1998-12-29 | Hewlett-Packard Company | Signal enhancement method and kit |
US7244732B2 (en) * | 2003-06-20 | 2007-07-17 | Koronis Pharmaceuticals, Incorporated | Prodrugs of heteroaryl compounds |
US7250416B2 (en) | 2005-03-11 | 2007-07-31 | Supergen, Inc. | Azacytosine analogs and derivatives |
US7700567B2 (en) | 2005-09-29 | 2010-04-20 | Supergen, Inc. | Oligonucleotide analogues incorporating 5-aza-cytosine therein |
KR102004559B1 (en) | 2011-08-30 | 2019-07-26 | 아스텍스 파마수티컬스, 인크. | Decitabine derivative formulations |
JP6768722B2 (en) | 2015-07-02 | 2020-10-14 | 大塚製薬株式会社 | Lyophilized pharmaceutical composition |
BR112020002280A2 (en) | 2017-08-03 | 2020-07-28 | Otsuka Pharmaceutical Co., Ltd. | pharmacological compound and purification methods |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4358535A (en) * | 1980-12-08 | 1982-11-09 | Board Of Regents Of The University Of Washington | Specific DNA probes in diagnostic microbiology |
CA2006008C (en) * | 1988-12-20 | 2000-02-15 | Donald J. Kessler | Method for making synthetic oligonucleotides which bind specifically to target sites on duplex dna molecules, by forming a colinear triplex, the synthetic oligonucleotides and methods of use |
AU651067B2 (en) * | 1989-06-19 | 1994-07-14 | Johns Hopkins University, The | Formation of triple helix complexes of double stranded DNA using nucleoside oligomers |
WO1992010590A1 (en) * | 1990-12-10 | 1992-06-25 | Gilead Sciences, Inc. | Inhibition of transcription by formation of triple helixes |
-
1992
- 1992-10-01 IL IL103311A patent/IL103311A0/en unknown
- 1992-10-02 NZ NZ244606A patent/NZ244606A/en unknown
- 1992-10-05 AU AU27852/92A patent/AU2785292A/en not_active Abandoned
- 1992-10-05 CA CA002119890A patent/CA2119890A1/en not_active Abandoned
- 1992-10-05 WO PCT/US1992/008458 patent/WO1993007295A1/en not_active Application Discontinuation
- 1992-10-05 JP JP5507113A patent/JPH07501936A/en active Pending
- 1992-10-05 EP EP92921942A patent/EP0650526A4/en not_active Withdrawn
-
1997
- 1997-06-13 AU AU24881/97A patent/AU2488197A/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
EP0650526A4 (en) | 1998-02-04 |
JPH07501936A (en) | 1995-03-02 |
AU2785292A (en) | 1993-05-03 |
CA2119890A1 (en) | 1993-04-15 |
NZ244606A (en) | 1997-07-27 |
AU2488197A (en) | 1997-09-04 |
EP0650526A1 (en) | 1995-05-03 |
WO1993007295A1 (en) | 1993-04-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB9212164D0 (en) | Preparation of nucleic acids | |
AU5748986A (en) | Conductive coatings for elongated conductors | |
GB8926026D0 (en) | Extended nucleotide sequences | |
IL94752A0 (en) | Formation of triple helix complexes of double stranded dna using nucleoside oligomers | |
IL103311A0 (en) | Formation of triple helix complexes of single stranded nucleic acids using nucleoside oligomers | |
GB9122060D0 (en) | Method of sequencing double stranded dna | |
AU3933393A (en) | Nucleic acid sequences having single stranded ends | |
AU6442686A (en) | Sheathed fence wire | |
IL102983A0 (en) | Formation of triple helix complexes of double stranded dna using nucleoside oligomers which comprise purine base analogs | |
AU4800793A (en) | Electrophoresis of nucleic acid fragments | |
IL107616A0 (en) | Formation of triple helix complexes of single stranded nucleic acids using nucleoside oligomers which comprise pyrimidine analogs | |
ZA9210008B (en) | Manipulating nucleic acid sequences | |
AU4045693A (en) | Electrophoresis of nucleic acid fragments | |
GB9207598D0 (en) | Method of sequencing double stranded dna | |
IL107934A0 (en) | Formation of triple helix complexes | |
GB2210514B (en) | Terminating insulated conductors | |
GB2222164B (en) | Nucleotide derivatives | |
GB9323035D0 (en) | Nucleotide sequences | |
GB9216882D0 (en) | Manipulating nucleic acid sequences | |
GB9112799D0 (en) | Nucleic acid sequences | |
GB8827544D0 (en) | Extended nucleotide sequences | |
GB9112796D0 (en) | Nucleic acids | |
GB9126359D0 (en) | Nucleic acids | |
GB9112797D0 (en) | Nucleotide sequences | |
GB9113666D0 (en) | Nucleotide sequences |